Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Cundy

Showing results (51-60 of 54) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 54 results.
RSC Medicinal Chemistry|February 27, 2023
Novel irreversible peptidic inhibitors of transglutaminase 2Nicholas J Cundy, Jane Arciszewski, Eric W J Gates, et al.
The Journal of Bone and Joint Surgery. American Volume|July 22, 2016
Evaluation of Brace Treatment for Infant Hip Dislocation in a Prospective Cohort: Defining the Success Rate and Variables Associated with FailureVidyadhar V Upasani, James D Bomar, Travis H Matheney, et al.
Journal of Medicinal Chemistry|February 8, 2024
Azetidines Kill Multidrug-Resistant <i>Mycobacterium tuberculosis</i> without Detectable Resistance by Blocking Mycolate AssemblyYixin Cui, Alice Lanne, Xudan Peng, et al.
Immunity|May 24, 2024
A RIPK1-specific PROTAC degrader achieves potent antitumor activity by enhancing immunogenic cell deathJonathan Mannion, Valentina Gifford, Benjamin Bellenie, et al.
Pageof 6

Showing results (51-60 of 54) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 54 results.
RSC Medicinal Chemistry|February 27, 2023
Novel irreversible peptidic inhibitors of transglutaminase 2Nicholas J Cundy, Jane Arciszewski, Eric W J Gates, et al.
The Journal of Bone and Joint Surgery. American Volume|July 22, 2016
Evaluation of Brace Treatment for Infant Hip Dislocation in a Prospective Cohort: Defining the Success Rate and Variables Associated with FailureVidyadhar V Upasani, James D Bomar, Travis H Matheney, et al.
Journal of Medicinal Chemistry|February 8, 2024
Azetidines Kill Multidrug-Resistant <i>Mycobacterium tuberculosis</i> without Detectable Resistance by Blocking Mycolate AssemblyYixin Cui, Alice Lanne, Xudan Peng, et al.
Immunity|May 24, 2024
A RIPK1-specific PROTAC degrader achieves potent antitumor activity by enhancing immunogenic cell deathJonathan Mannion, Valentina Gifford, Benjamin Bellenie, et al.
Pageof 6